HK Stock Market Move | MEDBOT-B(02252) rose over 8% in the final trading session with the company's order trend strong. Siasun Robot & Automation is leading the new revolution in clinical surgery.

MEDBOT-B (02252) rose more than 8% in the closing session, with a gain of 8.23% as of the time of publication, reaching HK$15.78 with a trading volume of HK$1.48 billion. On the news front, MicroPort Siasun Robot & Automation had previously announced its annual performance, with shareholders' net loss of 642 million yuan in 2024, a 36.5% decrease year-on-year. JP Morgan had pointed out earlier that MicroPort Siasun Robot & Automation's order trend is strong, with the company's sales contribution to MICROPORT expected to increase from about 3% in 2024 to about 40% in 2033 due to the rapid expansion of installations of Siasun Robot & Automation in China and overseas. Industrial indicated that due to the substantial global market space for surgical Siasun Robot & Automation and the "equipment + consumables/services" business model with high customer stickiness and sustainability, Intuitive Surgical, with its innovative products leading the market, stable market share, and steady growth performance, enjoys a higher valuation in the US stock market. It is recommended to pay attention to leading domestic surgical Siasun Robot & Automation companies with competitive products and continuous innovation, such as MicroPort Siasun Robot & Automation.